Hongo F - Search Results

1

Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.

Seligson DB, Hongo F, Huerta-Yepez S, Mizutani Y, Miki T, Yu H, Horvath S, Chia D, Goodglick L, Bonavida B. Seligson DB, et al. Among authors: hongo f. Clin Cancer Res. 2007 Oct 15;13(20):6056-63. doi: 10.1158/1078-0432.CCR-07-0960. Clin Cancer Res. 2007. PMID: 17947468

2

Significance of serum soluble Fas ligand in patients with bladder carcinoma.

Mizutani Y, Hongo F, Sato N, Ogawa O, Yoshida O, Miki T. Mizutani Y, et al. Among authors: hongo f. Cancer. 2001 Jul 15;92(2):287-93. doi: 10.1002/1097-0142(20010715)92:2<287::aid-cncr1321>3.0.co;2-4. Cancer. 2001. PMID: 11466681

3

Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.

Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B. Huerta-Yepez S, et al. Among authors: hongo f. Oncogene. 2004 Jun 24;23(29):4993-5003. doi: 10.1038/sj.onc.1207655. Oncogene. 2004. PMID: 15048072

4

Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.

Hongo F, Garban H, Huerta-Yepez S, Vega M, Jazirehi AR, Mizutani Y, Miki T, Bonavida B. Hongo F, et al. Biochem Biophys Res Commun. 2005 Oct 21;336(2):692-701. doi: 10.1016/j.bbrc.2005.08.150. Biochem Biophys Res Commun. 2005. PMID: 16143308

5

Gene therapy with TRAIL against renal cell carcinoma.

Matsubara H, Mizutani Y, Hongo F, Nakanishi H, Kimura Y, Ushijima S, Kawauchi A, Tamura T, Sakata T, Miki T. Matsubara H, et al. Among authors: hongo f. Mol Cancer Ther. 2006 Sep;5(9):2165-71. doi: 10.1158/1535-7163.MCT-05-0522. Mol Cancer Ther. 2006. PMID: 16985049

6

Feasibility of tri-weekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.

Takaha N, Okihara K, Kamoi K, Hongo F, Iwata T, Yano K, Ueda T, Takeuchi I, Yamada T, Kawauchi A, Miki T. Takaha N, et al. Among authors: hongo f. Urol Int. 2011;87(3):263-9. doi: 10.1159/000328217. Epub 2011 Aug 26. Urol Int. 2011. PMID: 21876321

7

High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.

Takeuchi I, Takaha N, Nakamura T, Hongo F, Mikami K, Kamoi K, Okihara K, Kawauchi A, Miki T. Takeuchi I, et al. Among authors: hongo f. Prostate. 2012 Jul 1;72(10):1124-32. doi: 10.1002/pros.22460. Epub 2011 Dec 27. Prostate. 2012. PMID: 22213442

8

Expression and role of HMGA1 in renal cell carcinoma.

Takaha N, Sowa Y, Takeuchi I, Hongo F, Kawauchi A, Miki T. Takaha N, et al. Among authors: hongo f. J Urol. 2012 Jun;187(6):2215-22. doi: 10.1016/j.juro.2012.01.069. Epub 2012 Apr 13. J Urol. 2012. PMID: 22503056

9

[Management of side effects of everolimus treatment for metastatic renal cell carcinoma].

Mikami K, Hongo F, Miki T. Mikami K, et al. Among authors: hongo f. Hinyokika Kiyo. 2012 Nov;58(11):647-50. Hinyokika Kiyo. 2012. PMID: 23254794 Free article. Japanese.

10

Identification of a novel gene by whole human genome tiling array.

Ishida H, Yagi T, Tanaka M, Tokuda Y, Kamoi K, Hongo F, Kawauchi A, Nakano M, Miki T, Tashiro K. Ishida H, et al. Among authors: hongo f. Gene. 2013 Mar 1;516(1):33-8. doi: 10.1016/j.gene.2012.11.076. Epub 2012 Dec 19. Gene. 2013. PMID: 23261826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters